Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
45301
Histological sections of fat grafts that were removed from the PBS-treated, low-dose, and high-dose EPO treated mice 15 week after fat transplantation.
Published 2013“…Each bar represents the mean CD68-positive cells or MVD ± SD from five regions of interest in each fat graft from each treatment group at the end of the 15-week study period. …”
-
45302
-
45303
-
45304
-
45305
-
45306
-
45307
S1 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
45308
S3 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
45309
S2 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
45310
S5 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
45311
S6 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
45312
S4 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
45313
S7 Data -
Published 2025“…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
-
45314
TAp63 and p53 mutants display reduced proliferation in basal layers and reduced differentiation in upper layers of tubercle remnants.
Published 2014“…(F) Distribution of phenotypic strengths (n, normal; C1, intermediate; C2, strong) in lower jaw tubercles of wild-type, TAp63 mutant, p53 mutant and TAp63/p53 double mutant fish at an age of 50 days (upper panel) and 1 year (lower panel), determined via calcein staining (for example, see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004048#pgen-1004048-g008" target="_blank">Figure 8V,X</a>). …”
-
45315
Ticagrelor treatment, but not clopidogrel treatment, induces the praroxonase-1 (PON1) message, increases tissue and serum PON1 protein, and mitigates atherosclerosis.
Published 2019“…<p>Abbreviations: CTL, control; CLO, clopidogrel; TIC, ticagrelor; RNA-Seq, RNA sequencing using next generation sequencing; PON1, paraoxonase 1; A.U., arbitrary unit; N = 5 per group; Error bars, means ± SD, statistical analyses performed using one-way ANOVA test with Fisher’s multiple comparisons; <i>NS</i>, not statistically significant; *, P < 0.05; **, P < 0.01 <i>(See also <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0218934#pone.0218934.s005" target="_blank">S5 Fig</a>).…”
-
45316
DataSheet1_A New Definition for Intracranial Compliance to Evaluate Adult Hydrocephalus After Shunting.PDF
Published 2022“…<p>The clinical application of intracranial compliance (ICC), ∆V/∆P, as one of the most critical indexes for hydrocephalus evaluation was demonstrated previously. …”
-
45317
Table_1_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx
Published 2023“…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
-
45318
Table_3_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx
Published 2023“…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
-
45319
Table_1_Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.docx
Published 2022“…After a median follow-up of 69 months, the 5-year rate of DFS, BCSS, and LRR in the overall cohort was 90.2%, 97.4%, and 3.6%, respectively. …”
-
45320
Table_2_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx
Published 2023“…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”